The Winners of the 2017 Galien MedStartUp Awards in Medical Technology Innovation Announced in New York [fr]
On October 27th, Business France and the Galien Foundation awarded four prizes to the winners of the 4th edition of the Prix Galien MedStartUp 2017, during a ceremony held in New York. It brought together the biggest names in the medical and pharmaceutical industry, and was also the opportunity to highlight the possible partnerships between the United States and France in the field of medical innovation.
Since 2014, Business France and the Galien Foundation have partnered to foster and reward international partnerships in pharmaceutical, medical device and digital health innovation. Each year, the Medstartup Conference invites some of the most prestigious American pharmaceutical companies to meet with 50 of the most innovative French Startups.
According to Henri Baissas, Director of Business France North America: “The United States represents close to a quarter of foreign investments in the French pharmaceutical sector and 40% of the medical one. The Prix Galien Medstartup is a great opportunity to highlight this existing and very strong relationship and we are thrilled to work with the Galien Foundation every year to introduce the best of French biotech innovation to the American Pharmaceutical industry.”
The jury of the 2017 Galien MedStartUp Award, chaired by Bernard Poussot, Director of Roche Holding and former Chairman & CEO of Wyeth, bestowed the prize for the “Best Collaboration with Academia Leading to a Breakthough Solution” upon Protecsom. This startup collaborated with Virginia Commonwealth University & Pharmasystems to create digit’hal®, a product designed to help patients manage their inhaled treatments. The “Best Use of Patient Engagement Technologies” award was also given to Protecsom for their work with the Quebec Pulmonary Association & Pharmasystems in this area.
The prize for the “Best Innovative Trial Design Leading to Quicker by and Better Therapeutic Outcome” was awarded to Quantum Genomics. This startup teamed up with Medpace to manage a clinical study of hypertensive overweight patients from multiple ethnic groups in 25 hospitals in United-States.
Finally, the prize for the “Best Collaboration or Partnership Leading to a Breakthrough Solution Dedicated to the In-developing Countries” was bestowed on Integrage. Together with Solution Lab, this startup developed the ICE (Interpretation of Clinical Exome) software program that will aid in the interpretation of genome sequencing data obtained from cancer patients.
According to Bruno Cohen, President of the Galien Foundation, “the Medstartup program and awards are a perfect illustration of the long and mutually beneficial collaboration between France and the USA, always leading to breakthrough innovations.”